206 related articles for article (PubMed ID: 26683818)
1. LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer.
Zheng J; Wang F; Lu S; Wang X
Exp Mol Pathol; 2016 Feb; 100(1):116-24. PubMed ID: 26683818
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
3. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
5. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Wang H; Li W; Jin X; Cui S; Zhao L
Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
[TBL] [Abstract][Full Text] [Related]
6. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
Yang W; Zhou C; Luo M; Shi X; Li Y; Sun Z; Zhou F; Chen Z; He J
Oncotarget; 2016 Mar; 7(13):16703-15. PubMed ID: 26934648
[TBL] [Abstract][Full Text] [Related]
7. Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.
Shi J; Guo J; Li X
Int J Oncol; 2018 Jan; 52(1):179-188. PubMed ID: 29138807
[TBL] [Abstract][Full Text] [Related]
8. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
10. LASP-1 promotes tumor proliferation and metastasis and is an independent unfavorable prognostic factor in gastric cancer.
Zheng J; Yu S; Qiao Y; Zhang H; Liang S; Wang H; Liu Y; Zhou F; Jiang J; Lu S
J Cancer Res Clin Oncol; 2014 Nov; 140(11):1891-9. PubMed ID: 24990592
[TBL] [Abstract][Full Text] [Related]
11. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2.
Wang LL; Zhang M
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7760-7767. PubMed ID: 30536321
[TBL] [Abstract][Full Text] [Related]
12. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S
Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580
[TBL] [Abstract][Full Text] [Related]
13. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
Li W; Cui Y; Wang D; Wang Y; Wang L
Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568
[TBL] [Abstract][Full Text] [Related]
14. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
15. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.
Shi Q; Zhou Z; Ye N; Chen Q; Zheng X; Fang M
Cancer Biomark; 2017 Dec; 20(4):539-546. PubMed ID: 28946554
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of long non-coding RNA SNHG16 correlates with tumor progression and poor prognosis in non-small cell lung cancer.
Han W; Du X; Liu M; Wang J; Sun L; Li Y
Int J Biol Macromol; 2019 Jan; 121():270-278. PubMed ID: 30287374
[TBL] [Abstract][Full Text] [Related]
17. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
[TBL] [Abstract][Full Text] [Related]
18. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
[TBL] [Abstract][Full Text] [Related]
19. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.
Gao W; Han J
Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
[TBL] [Abstract][Full Text] [Related]
20. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]